Structures by: Nagy A.
Total: 6
C26H23Cl2N4O4,C7H7NO2
C26H23Cl2N4O4,C7H7NO2
Molecular pharmaceutics (2020)
a=9.7532(4)Å b=13.0997(6)Å c=14.7094(7)Å
α=65.035(5)° β=72.196(4)° γ=84.857(4)°
C26H23Cl2N4O4,C7H7NO2
C26H23Cl2N4O4,C7H7NO2
Molecular pharmaceutics (2020)
a=9.6678(5)Å b=12.9865(6)Å c=14.6942(7)Å
α=64.386(5)° β=71.962(4)° γ=85.754(4)°
C232H200Cl8N8O4P16Pd8
C232H200Cl8N8O4P16Pd8
Dalton transactions (Cambridge, England : 2003) (2004) 13 2041-2050
a=15.011(7)Å b=15.011(7)Å c=25.622(5)Å
α=90.00° β=90.00° γ=90.00°
C57H48BrCl2NOP4Pd2
C57H48BrCl2NOP4Pd2
Dalton transactions (Cambridge, England : 2003) (2004) 13 2041-2050
a=15.079(1)Å b=15.079(1)Å c=25.970(3)Å
α=90.00° β=90.00° γ=90.00°
C57H49Cl2NOP4Pd2
C57H49Cl2NOP4Pd2
Dalton transactions (Cambridge, England : 2003) (2004) 13 2041-2050
a=21.247(3)Å b=21.247(3)Å c=14.214(2)Å
α=90.00° β=90.00° γ=90.00°
C58H51Cl2NO2P4Pd2
C58H51Cl2NO2P4Pd2
Dalton transactions (Cambridge, England : 2003) (2004) 13 2041-2050
a=21.224(5)Å b=21.224(5)Å c=14.230(2)Å
α=90.00° β=90.00° γ=90.00°